Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
AVTX
AVTX News & Events
-
Add to Watchlist
Trade AVTX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
AVTX News
Avalo Therapeutics Completes Enrollment for AVTX-009 Trial
6 days ago
Benzinga
Valvoline Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations
Dec 18 2025
Benzinga
Avalo Therapeutics Reveals Inducement Grants for New Hires in Accordance with Nasdaq Listing Rule 5635(c)(4)
Nov 17 2025
Newsfilter
Avalo Therapeutics Completes Patient Enrollment in Phase 2 LOTUS Trial for AVTX-009 Targeting Hidradenitis Suppurativa Treatment
Oct 29 2025
Newsfilter
DFAS's Assets May Indicate a 15% Profit Opportunity
Oct 02 2025
NASDAQ.COM
Avalo Therapeutics Strengthens Leadership Team with Important New Hires in Business Development and HR
Oct 01 2025
Newsfilter
Merus Shares Surge 38%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 29 2025
Benzinga
Avalo Therapeutics Names Kevin R. Lind to Its Board of Directors
Sep 22 2025
Newsfilter
Show More News
AVTX Events
No data
AVTX Monitor News
No data
AVTX Earnings Analysis
No Data
People Also Watch
